ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer

I. Chow Joe Hsu, Yoshiya Yamada, Dean G. Assimos, Anthony V. D'Amico, Brian J. Davis, Steven J. Frank, Alexander R. Gottschalk, Gary S. Gustafson, Patrick W. McLaughlin, Paul L. Nguyen, Seth A. Rosenthal, Al V. Taira, Neha Vapiwala, Gregory Merrick

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Purpose: High-dose-rate (HDR) brachytherapy plays a potential curative role in the treatment of prostate cancer. An expert panel was convened to review the recent literature and reach a consensus on its appropriate clinical applications. Methods and Materials: The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed every 2 years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment. Results: A summary of HDR brachytherapy's clinical applications and recent literature review was completed. Three clinical variants were developed to address common HDR dose, fractionations, and indications for its use in definitive therapy for primary and local recurrent prostate cancer. The panel reached a consensus on the specific treatment approaches with numerical rating and commentary. Conclusions: In combining available medical literature and expert opinion, this manuscript may serve as an aid for other practitioners in the appropriate application of HDR brachytherapy for prostate cancer.

Original languageEnglish (US)
Pages (from-to)27-31
Number of pages5
JournalBrachytherapy
Volume13
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Appropriateness criteria
  • Brachytherapy
  • HDR
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer'. Together they form a unique fingerprint.

  • Cite this

    Hsu, I. C. J., Yamada, Y., Assimos, D. G., D'Amico, A. V., Davis, B. J., Frank, S. J., Gottschalk, A. R., Gustafson, G. S., McLaughlin, P. W., Nguyen, P. L., Rosenthal, S. A., Taira, A. V., Vapiwala, N., & Merrick, G. (2014). ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy, 13(1), 27-31. https://doi.org/10.1016/j.brachy.2013.11.007